126 - 150 of 522
Number of results to display per page
TitleDateTypeSetname
126Treatment of Pendular Nystagmus with Gabapentin and Memantine in Patients with Multiple Sclerosis: Functional Aspects2014-03-04Textehsl_novel_nam
127We Can Hardly Believe Our Eyes2023-03Textehsl_novel_fbw
128We Can Hardly Believe Our Eyes2023-03Textehsl_novel_fbw
129We Can Hardly Believe Our Eyes2023-03Image/MovingImageehsl_novel_fbw
130Assessment of color vision in MS using a smartphone platform2014-03-04Textehsl_novel_nam
131Binocular Summation of High- And Low-Contrast Visual Acuities in Multiple Sclerosis Patients Compared with Normal Humans2011-02-08Textehsl_novel_nam
132Comparing Retinal Nerve Fiber Layer Atrophy and Disability in Multiple Sclerosis2009-02-24Textehsl_novel_nam
133Damping of Monocular Pendular Nystagmus with Vibration2014-03-04Textehsl_novel_nam
134Factors in Optic Nerve Conduction - VEP Analysis1983-02-16Textehsl_novel_nam
135Functional Connectivity in Patients with Clinically Isolated Optic Neuritis2013-02-12Textehsl_novel_nam
136Functional Connectivity in Patients with Clinically Isolated Optic Neuritis2013-02-12Textehsl_novel_nam
137Gene Expression Patterns of Peripheral Blood-Cells Subpopulations in Acute Optic Neuritis2009-02-23Textehsl_novel_nam
138Highlights From the 2014 Joint Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)ehsl_novel_jno
139Idiopathic Chiasmal Neuritis2007-02-13Textehsl_novel_nam
140Macular Thickening by OCT In a Phase III Trial of Fingolimod: The Importance of Quality Control2012-02-14Textehsl_novel_nam
141MS Treatment/Immune System Targets2023-03Textehsl_novel_nam
142MS Treatment/Immune System Targets2023-03Image/MovingImageehsl_novel_nam
143Multifocal Objective Pupil Perimetry in Multiple Sclerosis2011-02-08Textehsl_novel_nam
144Multiple sclerosis1997-01-01ehsl_heal
145Multiple sclerosis1997-01-01ehsl_heal
146Multiple sclerosis, spinal cord, plaque1997-01-01ehsl_heal
147Neuroprotective Effects of ST266 in Experimental Optic Neuritis (.pdf)2016-03-01Textehsl_novel_nam
148Optic NeuritisTextehsl_novel_wht
149Platform Presentation: The SIRT1 Activator SRT501 Attenuates Retinal Ganglion Cell Loss and Preserves Axonal Function During Acute Optic Neuritis2007-02-12Textehsl_novel_nam
150Prospective Study of the Risk of Developing Multiple Sclerosis in Uncomplicated Optic Neuritis: A 13 Year Follow-Up1986-02-24Textehsl_novel_nam
126 - 150 of 522